Skip to main content

IntelGenx Technologies Corp.

IGXTDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001098880

IntelGenx Technologies Corp. was delisted in 2024; its insiders filed their last Form 4 on May 3, 2024; 1 institution reported holding it in 13F filings for Q1 2024, worth $414 in total; no superinvestor held it.

Holders of 5% or more of IGXT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of IntelGenx Technologies Corp., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of IntelGenx Technologies Corp. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on IntelGenx Technologies Corp., newest first.

No Schedule 13D or 13G filings on IntelGenx Technologies Corp. are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell IntelGenx Technologies Corp. shares.

No Form 144 notices for IntelGenx Technologies Corp. are on file.